{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:11:45Z","timestamp":1769040705859,"version":"3.49.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.sapharm.2023.05.003","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T01:13:14Z","timestamp":1684285994000},"page":"1157-1170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A scoping literature review of pharmacy-based opioid misuse screening and brief interventions"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2927-7639","authenticated-orcid":false,"given":"Deepika","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meg","family":"Mercy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"McAtee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olayinka O.","family":"Shiyanbola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2023.05.003_bib1","series-title":"CDC","year":"2022"},{"key":"10.1016\/j.sapharm.2023.05.003_bib3","series-title":"White Paper on Screening, Brief Intervention and Referral to Treatment (SBIRT) in Behavioral Healthcare","year":"2011"},{"issue":"2","key":"10.1016\/j.sapharm.2023.05.003_bib4","first-page":"128","article-title":"Brief intervention in primary care settings. A primary treatment method for at-risk, problem, and dependent drinkers","volume":"23","author":"Fleming","year":"1999","journal-title":"Alcohol Res Health"},{"issue":"5","key":"10.1016\/j.sapharm.2023.05.003_bib5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11606-006-5063-z","article-title":"Meta-analysis of randomized control trials addressing brief interventions in heavy alcohol drinkers","volume":"12","author":"Wilk","year":"1997","journal-title":"J Gen Intern Med"},{"issue":"3","key":"10.1016\/j.sapharm.2023.05.003_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-146-3-200702060-00005","article-title":"Brief intervention for medical inpatients with unhealthy alcohol use: a randomized, controlled trial","volume":"146","author":"Saitz","year":"2007","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.sapharm.2023.05.003_bib7","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/archinte.165.9.986","article-title":"Reduction of alcohol consumption by brief alcohol intervention in primary care: systematic review and meta-analysis","volume":"165","author":"Bertholet","year":"2005","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.sapharm.2023.05.003_bib8","first-page":"Cd011479","article-title":"Personalised digital interventions for reducing hazardous and harmful alcohol consumption in community-dwelling populations","volume":"9","author":"Kaner","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.sapharm.2023.05.003_bib9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.amepre.2016.04.013","article-title":"Alcohol electronic screening and brief intervention: a community guide systematic review","volume":"51","author":"Tansil","year":"2016","journal-title":"Am J Prev Med"},{"issue":"1-3","key":"10.1016\/j.sapharm.2023.05.003_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.drugalcdep.2008.08.003","article-title":"Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later","volume":"99","author":"Madras","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.sapharm.2023.05.003_bib11","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/jama.2014.7862","article-title":"Screening and brief intervention for drug use in primary care: the ASPIRE randomized clinical trial","volume":"312","author":"Saitz","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.sapharm.2023.05.003_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/ajhp\/zxy003","article-title":"Impact of a pharmacist-directed pain management service on inpatient opioid use, pain control, and patient safety","volume":"76","author":"Poirier","year":"2019","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2023.05.003_bib13","first-page":"1","article-title":"Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders","volume":"14","author":"Bach","year":"2019","journal-title":"Addiction Sci Clin Pract"},{"issue":"8","key":"10.1016\/j.sapharm.2023.05.003_bib14","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.sapharm.2017.12.009","article-title":"Promising roles for pharmacists in addressing the US opioid crisis","volume":"15","author":"Compton","year":"2019","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2023.05.003_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13722-019-0158-0","article-title":"Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders","volume":"14","author":"Bach","year":"2019","journal-title":"Addiction Sci Clin Pract"},{"issue":"9","key":"10.1016\/j.sapharm.2023.05.003_bib16","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2105\/AJPH.2012.301165","article-title":"Designing for dissemination among public health researchers: findings from a national survey in the United States","volume":"103","author":"Brownson","year":"2013","journal-title":"Am J Publ Health"},{"issue":"1","key":"10.1016\/j.sapharm.2023.05.003_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0898010111412189","article-title":"A concept analysis of person-centered care","volume":"30","author":"Morgan","year":"2012","journal-title":"J Holist Nurs"},{"issue":"7","key":"10.1016\/j.sapharm.2023.05.003_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.sapharm.2023.05.003_bib19","series-title":"Scoping Review of Opioid Misuse Screening and Brief Interventions in Pharmacy Settings","author":"Rao","year":"2021"},{"issue":"6","key":"10.1016\/j.sapharm.2023.05.003_bib20","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1365-2753.2009.01314.x","article-title":"Let Evidence Guide Every New Decision (LEGEND): an evidence evaluation system for point-of-care clinicians and guideline development teams","volume":"15","author":"Clark","year":"2009","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.sapharm.2023.05.003_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107570","article-title":"A community pharmacy-led intervention for opioid medication misuse: a small-scale randomized clinical trial","volume":"205","author":"Cochran","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.sapharm.2023.05.003_bib22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.japh.2018.03.005","article-title":"A community pharmacy intervention for opioid medication misuse: a pilot randomized clinical trial","volume":"58","author":"Cochran","year":"2018","journal-title":"J Am Pharmaceut Assoc"},{"issue":"4","key":"10.1016\/j.sapharm.2023.05.003_bib23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/ajhp\/zxaa389","article-title":"Brief intervention medication therapy management: establishment of an opioid misuse intervention model delivered in a community pharmacy","volume":"78","author":"Kenney","year":"2021","journal-title":"Am J Health Syst Pharm : AJHP : official journal of the American Society of Health-System Pharmacists"},{"key":"10.1016\/j.sapharm.2023.05.003_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2022.106759","article-title":"Addressing opioid medication misuse at point of service in community pharmacy: a study protocol for an interdisciplinary behavioral health trial","volume":"116","author":"Cochran","year":"2022","journal-title":"Contemp Clin Trials"},{"issue":"4","key":"10.1016\/j.sapharm.2023.05.003_bib25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/ajhp\/zxaa387","article-title":"Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order","volume":"78","author":"Santa","year":"2021","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"10.1016\/j.sapharm.2023.05.003_bib26","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2105\/AJPH.2019.305060","article-title":"A primary prevention approach to the opioid epidemic","volume":"109","author":"Strand","year":"2019","journal-title":"Am J Publ Health"},{"issue":"8","key":"10.1016\/j.sapharm.2023.05.003_bib27","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.sapharm.2018.07.011","article-title":"Moving opioid misuse prevention upstream: a pilot study of community pharmacists screening for opioid misuse risk","volume":"15","author":"Strand","year":"2019","journal-title":"Res Soc Adm Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2023.05.003_bib28","article-title":"Opioid risk screening: program evaluation from the community pharmacists' perspective","volume":"62","author":"Frenzel","year":"2022","journal-title":"J Am Pharmaceut Assoc : J Am Pharm Assoc JAPhA"},{"key":"10.1016\/j.sapharm.2023.05.003_bib29","article-title":"Patient experience and satisfaction with opioid-related screening and intervention in North Dakota community pharmacies","author":"Lothspeich","year":"2022","journal-title":"J Pharm Pract"},{"issue":"1","key":"10.1016\/j.sapharm.2023.05.003_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.japh.2019.09.003","article-title":"Implementation of a statewide program within community pharmacies to prevent opioid misuse and accidental overdose","volume":"60","author":"Skoy","year":"2020","journal-title":"J Am Pharmaceut Assoc"},{"key":"10.1016\/j.sapharm.2023.05.003_bib31","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.5888\/pcd19.220028","article-title":"Evaluation of a program to screen patients in community pharmacies for opioid misuse and accidental overdose","volume":"19","author":"Skoy","year":"2022","journal-title":"Prev Chronic Dis"},{"issue":"4","key":"10.1016\/j.sapharm.2023.05.003_bib32","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1080\/08897077.2020.1827126","article-title":"Patient acceptance of naloxone resulting from targeted intervention from community pharmacists to prevent opioid misuse and accidental overdose","volume":"42","author":"Skoy","year":"2021","journal-title":"Subst Abuse"},{"issue":"9","key":"10.1016\/j.sapharm.2023.05.003_bib33","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.sapharm.2019.11.016","article-title":"Program evaluation of the opioid and naloxone education (ONE Rx) program using the RE-AIM model","volume":"16","author":"Strand","year":"2020","journal-title":"Res Soc Adm Pharm"},{"issue":"8","key":"10.1016\/j.sapharm.2023.05.003_bib34","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.sapharm.2018.10.024","article-title":"Routine opioid outcome monitoring in community pharmacy: pilot implementation study protocol","volume":"15","author":"Nielsen","year":"2019","journal-title":"Res Soc Adm Pharm"},{"issue":"12","key":"10.1016\/j.sapharm.2023.05.003_bib35","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.sapharm.2020.02.009","article-title":"Routine opioid outcome monitoring in community pharmacy: outcomes from an open-label single-arm implementation-effectiveness pilot study","volume":"16","author":"Nielsen","year":"2020","journal-title":"Res Soc Adm Pharm"},{"issue":"2","key":"10.1016\/j.sapharm.2023.05.003_bib36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11096-020-01074-5","article-title":"What predicts pharmacists\u2019 engagement with opioid-outcome screening? Secondary analysis from an implementation study in community pharmacy","volume":"43","author":"Nielsen","year":"2021","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"10.1016\/j.sapharm.2023.05.003_bib37","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/ajhp\/zxaa407","article-title":"The innovative role of an \"opioid overdose prevention pharmacist\" at a mental health teaching hospital","volume":"78","author":"Costa","year":"2021","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"10.1016\/j.sapharm.2023.05.003_bib38","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1016\/j.japh.2017.01.005","article-title":"Indian Health Service pharmacists engaged in opioid safety initiatives and expanding access to naloxone","volume":"57","author":"Duvivier","year":"2017","journal-title":"J Am Pharmaceut Assoc"},{"issue":"4","key":"10.1016\/j.sapharm.2023.05.003_bib39","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ajhp\/zxaa408","article-title":"The substance use intervention team: a hospital-based intervention and outpatient clinic to improve care for patients with substance use disorders","volume":"78","author":"Tran","year":"2021","journal-title":"Am J Health Syst Pharm"},{"issue":"5","key":"10.1016\/j.sapharm.2023.05.003_bib40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/ADM.0000000000000525","article-title":"Screening, brief intervention, and referral to treatment in a retail pharmacy setting: the Pharmacist's role in identifying and addressing risk of substance use disorder","volume":"13","author":"Shonesy","year":"2019","journal-title":"J Addiction Med"},{"issue":"5","key":"10.1016\/j.sapharm.2023.05.003_bib41","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1177\/1060028014523730","article-title":"Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings","volume":"48","author":"Bailey","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.sapharm.2023.05.003_bib42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11469-016-9640-z","article-title":"A comparative exploration of community pharmacists' views on the nature and management of over-the-counter (OTC) and prescription codeine misuse in three regulatory regimes: Ireland, South Africa and the United Kingdom","volume":"14","author":"Carney","year":"2016","journal-title":"Int J Ment Health Addiction"},{"issue":"4","key":"10.1016\/j.sapharm.2023.05.003_bib43","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/0897190014522064","article-title":"Pharmacists who screen and discuss opioid misuse with patients: future directions for research and practice","volume":"28","author":"Cochran","year":"2015","journal-title":"J Pharm Pract"},{"issue":"2","key":"10.1016\/j.sapharm.2023.05.003_bib44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jphs.12013","article-title":"Pharmacists' knowledge, attitudes and beliefs regarding screening and brief intervention for prescription opioid abuse: a survey of U tah and T exas pharmacists","volume":"4","author":"Cochran","year":"2013","journal-title":"J Pharmaceut Health Serv Res"},{"issue":"4","key":"10.1016\/j.sapharm.2023.05.003_bib45","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/CEH.0000000000000317","article-title":"Opioid misuse and overdose: changes in pharmacist practices and outcomes","volume":"40","author":"Eukel","year":"2020","journal-title":"J Continuing Educ Health Prof"},{"issue":"1","key":"10.1016\/j.sapharm.2023.05.003_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/CEH.0000000000000233","article-title":"Changes in pharmacists' perceptions after a training in opioid misuse and accidental overdose prevention","volume":"39","author":"Eukel","year":"2019","journal-title":"J Continuing Educ Health Prof"},{"issue":"8","key":"10.1016\/j.sapharm.2023.05.003_bib47","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.sapharm.2018.10.027","article-title":"Using the theory of planned behavior to investigate community pharmacists' beliefs regarding engaging patients about prescription drug misuse","volume":"15","author":"Fleming","year":"2019","journal-title":"Res Soc Adm Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2023.05.003_bib48","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1331\/JAPhA.2014.13168","article-title":"Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions","volume":"54","author":"Fleming","year":"2003","journal-title":"J Am Pharmaceut Assoc"},{"issue":"3","key":"10.1016\/j.sapharm.2023.05.003_bib49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1331\/JAPhA.2013.12094","article-title":"How does use of a prescription monitoring program change pharmacy practice?","volume":"53","author":"Green","year":"2003","journal-title":"J Am Pharmaceut Assoc"},{"issue":"6","key":"10.1016\/j.sapharm.2023.05.003_bib50","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.japh.2019.08.009","article-title":"Attitudes and perceptions of naloxone dispensing among a sample of Massachusetts community pharmacy technicians","volume":"59","author":"Kurian","year":"2003","journal-title":"J Am Pharmaceut Assoc"},{"issue":"5","key":"10.1016\/j.sapharm.2023.05.003_bib51","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.sapharm.2019.08.026","article-title":"Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C","volume":"16","author":"Meyerson","year":"2020","journal-title":"Res Soc Adm Pharm"},{"issue":"8","key":"10.1016\/j.sapharm.2023.05.003_bib52","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.sapharm.2018.02.004","article-title":"An opioid dispensing and misuse prevention algorithm for community pharmacy practice","volume":"15","author":"Rickles","year":"2019","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2023.05.003_bib53","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11096-021-01331-1","article-title":"Roles, barriers and behavioral determinants related to community pharmacists' involvement in optimizing opioid therapy for chronic pain: a qualitative study","volume":"44","author":"Alenezi","year":"2022","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.sapharm.2023.05.003_bib54","series-title":"Lofton. Pharmacists' Role in Addressing Opioid Abuse, Addiction, and Diversion","year":"2013"},{"key":"10.1016\/j.sapharm.2023.05.003_bib55","unstructured":"DiPaula Bethany A. GJJ, Love Raymond C. , Melton Sarah T. , Pikoulas Theodore , Puzantian Talia , Stock Christopher , Wehring Heidi Opioid Use Disorders: Interventions for Community Pharmacists. College of Psychiatric and Neurologic Pharmacists (CPNP)."},{"key":"10.1016\/j.sapharm.2023.05.003_bib57","series-title":"Role of Community Pharmacy in Improving Public Health","author":"Pringle","year":"2018"},{"issue":"9","key":"10.1016\/j.sapharm.2023.05.003_bib58","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/add.12950","article-title":"Specialty substance use disorder services following brief alcohol intervention: a meta-analysis of randomized controlled trials","volume":"110","author":"Glass","year":"2015","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.sapharm.2023.05.003_bib59","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/pm\/pnx139","article-title":"Pharmacists' role in opioid safety: a focus group investigation","volume":"19","author":"Hartung","year":"2017","journal-title":"Pain Med"},{"key":"10.1016\/j.sapharm.2023.05.003_bib60","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.japh.2017.01.013","article-title":"Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states","volume":"57","author":"Green","year":"2017","journal-title":"J Am Pharmaceut Assoc"},{"issue":"785","key":"10.1016\/j.sapharm.2023.05.003_bib61","first-page":"1161","article-title":"[Electronic screening and brief interventions]","volume":"18","author":"Bertholet","year":"2022","journal-title":"Rev Med Suisse"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155174112300253X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155174112300253X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:31:11Z","timestamp":1761557471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155174112300253X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S155174112300253X"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.05.003","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A scoping literature review of pharmacy-based opioid misuse screening and brief interventions","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}